NRIX - Nurix Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NRIX is currently covered by 15 analysts with an average price target of $31.5. This is a potential upside of $8.16 (34.96%) from yesterday's end of day stock price of $23.34.

Nurix Therapeutics's activity chart (see below) currently has 206 price targets and 206 ratings on display. The stock rating distribution of NRIX is 93.33% BUY and 6.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.32% with an average time for these price targets to be met of 146.34 days.

Highest price target for NRIX is $45, Lowest price target is $12, average price target is $31.5.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 10-Aug-2026. First documented stock forecast 18-Aug-2020.

Currently out of the existing stock ratings of NRIX, 56 are a BUY (93.33%), 4 are a HOLD (6.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Jun-2025

$36

$12.99 (56.45%)

$33

1 months 22 days ago
(10-Aug-2026)

0/5 (0%)

$10.12 (39.10%)

Buy Since 05-Jan-2022

$34

$10.99 (47.76%)

$34

1 months 28 days ago
(04-Aug-2026)

8/35 (22.86%)

$9.31 (37.71%)

278

Buy Since 28-Jul-2026

$38

$14.99 (65.15%)

$36

2 months 4 days ago
(28-Jul-2026)

5/7 (71.43%)

$13.85 (57.35%)

83

Buy Since 10-Apr-2025

$31

$7.99 (34.72%)

$30

2 months 10 days ago
(22-Jul-2026)

0/4 (0%)

$7.4 (31.36%)

Buy Since 27-Oct-2021

$34

$10.99 (47.76%)

$30

2 months 19 days ago
(13-Jul-2026)

1/7 (14.29%)

$11.29 (49.71%)

253

Show more analysts

Please expand the browser size to see the chart

What is NRIX (Nurix Therapeutics) average time for price targets to be met?

On average it took 146 days for the stock forecasts to be reached, with an average price target met ratio of 32.32%.

Which analyst most recently updated their price target on NRIX (Nurix Therapeutics)?

Brian Abrahams

Which analyst has the most public recommendations on NRIX (Nurix Therapeutics)?

Brian Abrahams works at RBC and has 99 price targets and 58 ratings on NRIX

Which analyst is the currently most bullish on NRIX (Nurix Therapeutics)?

Chad Messer with the highest potential upside of $24.99

Which analyst is the currently most reserved on NRIX (Nurix Therapeutics)?

Faisal Khurshid with the lowest potential downside of -$11.01
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?